ABBV-3373
Product Specifications
Target
Glucocorticoid Receptor, Antibody-Drug Conjugates (ADCs), TNF
Related Pathways
Apoptosis, Endocrinology/Hormones, Antibody-drug Conjugate/ADC Related
Bioactivity
ABBV-3373 is an anti-TNF antibody-drug conjugate (ADC) composed of the humanized TNF antibody adalimumab and a glucocorticoid receptor agonist. It is designed for use in research related to rheumatoid arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog